Gene Therapy For Thalassemia Needs To Be Safer

Gene Therapy For Thalassemia Needs To Be Safer

Gene Therapy For Thalassemia Needs To Be Safer Insertional oncogenesis is an inherent risk of lentiviral vectors because they are able to integrate into thousands of loci within the genome. Bluebird’s Lenti-D integrated into 1 or more oncogenes in nearly all 67 trial...